Hualan Biological Engineering Inc
SZSE:002007
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
13.84
24.44
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Hualan Biological Engineering Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | CN |
Market Cap | 30.1B CNY |
Operating Margin |
32%
|
Country | FR |
Market Cap | 6T USD |
Operating Margin |
-17 527%
|
Country | US |
Market Cap | 314.7B USD |
Operating Margin |
28%
|
Country | US |
Market Cap | 147.4B USD |
Operating Margin |
19%
|
Country | US |
Market Cap | 119.4B USD |
Operating Margin |
40%
|
Country | US |
Market Cap | 113.8B USD |
Operating Margin |
38%
|
Country | US |
Market Cap | 94.1B EUR |
Operating Margin |
-370%
|
Country | AU |
Market Cap | 135.4B AUD |
Operating Margin |
26%
|
Country | US |
Market Cap | 82.6B USD |
Operating Margin |
30%
|
Country | US |
Market Cap | 39.3B EUR |
Operating Margin |
-33%
|
Country | NL |
Market Cap | 34.3B EUR |
Operating Margin |
-22%
|
Hualan Biological Engineering Inc
Glance View
Hualan Biological Engineering, Inc. engages in the research and development, production, and sale of biological products. The company is headquartered in Xinxiang, Henan and currently employs 2,927 full-time employees. The company went IPO on 2004-06-25. The company also produces vaccine products and biological engineering products. The firm's main products include human albumins, human immunoglobulin for intravenous injection, human immunoglobulin, human coagulation factors, human rabies immunoglobulin, human tetanus immunoglobulin and influenza vaccines, among others. The firm mainly operates its businesses in domestic markets.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Hualan Biological Engineering Inc's most recent financial statements, the company has Operating Margin of 31.7%.